We utilized Transwell assays to explore the functional role of PLCB2 in RCC cell migration and invasion, revealing that a siRNA-mediated reduction in PLCB2 significantly impairs these capabilities in renal cancer cells (Figure 8C). The gene discussed is PLCB2; the disease is renal carcinoma.